Mylan acquires generic injectables unit from Strides Arcolab
Mylan announced that it has signed an agreement to acquire the generic injectables unit Agila Specialties from Strides Arcolab for $1.6 billion in cash.
University of Pittsburgh Medical Center senior advisor Robert Cindrich and Mylan President Heather Bresch have been named to the Mylan Inc. board of directors, the Canonsburg-based generic drug giant announced on Tuesday.